nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—ADRA2C—attention deficit hyperactivity disorder	0.604	0.701	CbGaD
Naphazoline—ADRA2A—attention deficit hyperactivity disorder	0.258	0.299	CbGaD
Naphazoline—Phentolamine—ADRA2C—attention deficit hyperactivity disorder	0.0021	0.329	CrCbGaD
Naphazoline—Tolazoline—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.194	CrCbGaD
Naphazoline—Phentolamine—ADRA2A—attention deficit hyperactivity disorder	0.000896	0.141	CrCbGaD
Naphazoline—Duloxetine—SLC6A3—attention deficit hyperactivity disorder	0.000562	0.0881	CrCbGaD
Naphazoline—Tolazoline—ADRA2A—attention deficit hyperactivity disorder	0.000528	0.0828	CrCbGaD
Naphazoline—Duloxetine—SLC6A4—attention deficit hyperactivity disorder	0.00042	0.0659	CrCbGaD
Naphazoline—Duloxetine—HTR2A—attention deficit hyperactivity disorder	0.000323	0.0507	CrCbGaD
Naphazoline—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.000309	0.0485	CrCbGaD
Naphazoline—NISCH—midbrain—attention deficit hyperactivity disorder	0.000182	0.111	CbGeAlD
Naphazoline—NISCH—cerebellum—attention deficit hyperactivity disorder	0.000141	0.0856	CbGeAlD
Naphazoline—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000132	0.0803	CbGeAlD
Naphazoline—ADRA2C—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000119	0.000916	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000118	0.000907	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000116	0.00089	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000116	0.00089	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000115	0.000883	CbGpPWpGaD
Naphazoline—NISCH—brain—attention deficit hyperactivity disorder	0.000115	0.0695	CbGeAlD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000875	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000113	0.000867	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000865	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000113	0.000865	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000864	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000113	0.000864	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000112	0.000862	CbGpPWpGaD
Naphazoline—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000112	0.0679	CbGeAlD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00011	0.000847	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00011	0.000847	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00011	0.000843	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000108	0.000831	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000106	0.000816	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000105	0.000805	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000105	0.000804	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000105	0.000803	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000803	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000104	0.0008	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000103	0.000793	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000103	0.00079	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000103	0.000789	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000103	0.000787	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000103	0.000787	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000101	0.000779	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000101	0.000778	CbGpPWpGaD
Naphazoline—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000101	0.0611	CbGeAlD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.96e-05	0.000765	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	9.93e-05	0.000763	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	9.85e-05	0.000756	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.84e-05	0.000755	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	9.76e-05	0.00075	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	9.72e-05	0.000747	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	9.69e-05	0.000744	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9.64e-05	0.00074	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	9.64e-05	0.00074	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	9.62e-05	0.000738	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	9.61e-05	0.000738	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	9.47e-05	0.000727	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	9.42e-05	0.000723	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	9.18e-05	0.000705	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	9.17e-05	0.000704	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.14e-05	0.000702	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.99e-05	0.000691	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	8.98e-05	0.00069	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.97e-05	0.000688	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	8.96e-05	0.000688	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	8.8e-05	0.000675	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.68e-05	0.000667	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.56e-05	0.000657	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.54e-05	0.000655	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	8.52e-05	0.000654	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.43e-05	0.000647	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.4e-05	0.000645	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	8.4e-05	0.000645	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.39e-05	0.000644	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.36e-05	0.000642	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.33e-05	0.00064	CbGpPWpGaD
Naphazoline—ADRA2C—midbrain—attention deficit hyperactivity disorder	8.33e-05	0.0505	CbGeAlD
Naphazoline—ADRA1A—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	8.3e-05	0.000638	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.1e-05	0.000622	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.07e-05	0.000619	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.96e-05	0.000611	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.86e-05	0.000604	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.86e-05	0.000604	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.85e-05	0.000603	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	7.84e-05	0.000602	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.83e-05	0.000601	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	7.81e-05	0.0006	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.81e-05	0.000599	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.78e-05	0.000597	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.62e-05	0.000585	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	7.56e-05	0.000581	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.44e-05	0.000571	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	7.43e-05	0.00057	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.34e-05	0.000564	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.34e-05	0.000564	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.34e-05	0.000564	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.32e-05	0.000562	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.3e-05	0.00056	CbGpPWpGaD
Naphazoline—ADRA1A—nervous system—attention deficit hyperactivity disorder	7.18e-05	0.0436	CbGeAlD
Naphazoline—ADRA2B—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	7.12e-05	0.000546	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.12e-05	0.000546	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.99e-05	0.000537	CbGpPWpGaD
Naphazoline—ADRA1A—central nervous system—attention deficit hyperactivity disorder	6.92e-05	0.042	CbGeAlD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.85e-05	0.000526	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.85e-05	0.000526	CbGpPWpGaD
Naphazoline—ADRA2C—nervous system—attention deficit hyperactivity disorder	6.84e-05	0.0415	CbGeAlD
Naphazoline—ADRA2C—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.84e-05	0.000525	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.83e-05	0.000524	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.82e-05	0.000524	CbGpPWpGaD
Naphazoline—ADRA1A—cerebellum—attention deficit hyperactivity disorder	6.76e-05	0.041	CbGeAlD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.74e-05	0.000517	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	6.65e-05	0.00051	CbGpPWpGaD
Naphazoline—ADRA2A—midbrain—attention deficit hyperactivity disorder	6.64e-05	0.0403	CbGeAlD
Naphazoline—ADRA1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.61e-05	0.000508	CbGpPWpGaD
Naphazoline—ADRA2C—central nervous system—attention deficit hyperactivity disorder	6.59e-05	0.04	CbGeAlD
Naphazoline—ADRA1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.5e-05	0.000499	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.5e-05	0.000499	CbGpPWpGaD
Naphazoline—ADRA2C—cerebellum—attention deficit hyperactivity disorder	6.44e-05	0.0391	CbGeAlD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.42e-05	0.000493	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.42e-05	0.000493	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.4e-05	0.000491	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.36e-05	0.000489	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.35e-05	0.000488	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.34e-05	0.000487	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.29e-05	0.000483	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.22e-05	0.000478	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.14e-05	0.000472	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.98e-05	0.000459	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.96e-05	0.000458	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.96e-05	0.000458	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.9e-05	0.000453	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.81e-05	0.000446	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.78e-05	0.000444	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.59e-05	0.000429	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.56e-05	0.000427	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.5e-05	0.000422	CbGpPWpGaD
Naphazoline—ADRA1A—brain—attention deficit hyperactivity disorder	5.49e-05	0.0333	CbGeAlD
Naphazoline—ADRA2A—nervous system—attention deficit hyperactivity disorder	5.46e-05	0.0331	CbGeAlD
Naphazoline—ADRA2C—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.43e-05	0.000417	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.35e-05	0.000411	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.28e-05	0.000405	CbGpPWpGaD
Naphazoline—ADRA2A—central nervous system—attention deficit hyperactivity disorder	5.26e-05	0.0319	CbGeAlD
Naphazoline—ADRA2C—brain—attention deficit hyperactivity disorder	5.23e-05	0.0318	CbGeAlD
Naphazoline—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.2e-05	0.000399	CbGpPWpGaD
Naphazoline—ADRA2A—cerebellum—attention deficit hyperactivity disorder	5.14e-05	0.0312	CbGeAlD
Naphazoline—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.13e-05	0.000394	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.11e-05	0.000392	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.08e-05	0.00039	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.99e-05	0.000383	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.93e-05	0.000379	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.79e-05	0.000368	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.75e-05	0.000365	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.75e-05	0.000365	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.73e-05	0.000363	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.62e-05	0.000354	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.59e-05	0.000353	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.58e-05	0.000351	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.5e-05	0.000346	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.5e-05	0.000345	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.44e-05	0.000341	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.41e-05	0.000339	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.41e-05	0.000339	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.41e-05	0.000339	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.37e-05	0.000335	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.31e-05	0.000331	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.31e-05	0.000331	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.29e-05	0.000329	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.27e-05	0.000328	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.2e-05	0.000323	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.2e-05	0.000323	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.19e-05	0.000322	CbGpPWpGaD
Naphazoline—ADRA2A—brain—attention deficit hyperactivity disorder	4.17e-05	0.0253	CbGeAlD
Naphazoline—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.17e-05	0.00032	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.16e-05	0.000319	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.15e-05	0.000319	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.15e-05	0.000319	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.14e-05	0.000318	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.12e-05	0.000317	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.08e-05	0.000314	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.06e-05	0.000311	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.03e-05	0.00031	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.01e-05	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.01e-05	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.89e-05	0.000299	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.88e-05	0.000298	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.87e-05	0.000297	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.86e-05	0.000296	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.86e-05	0.000296	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000293	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.77e-05	0.000289	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.77e-05	0.000289	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.76e-05	0.000289	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.75e-05	0.000288	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.74e-05	0.000287	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.67e-05	0.000282	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.67e-05	0.000282	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.63e-05	0.000279	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.6e-05	0.000277	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.59e-05	0.000275	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.54e-05	0.000272	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	3.54e-05	0.000272	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.51e-05	0.00027	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.5e-05	0.000269	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.5e-05	0.000269	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.49e-05	0.000268	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	3.48e-05	0.000268	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.47e-05	0.000267	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.41e-05	0.000262	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.39e-05	0.000261	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.38e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.37e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.35e-05	0.000257	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.34e-05	0.000256	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.29e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.26e-05	0.00025	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.24e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.15e-05	0.000242	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.14e-05	0.000241	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.00024	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.07e-05	0.000236	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.06e-05	0.000235	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.91e-05	0.000224	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.9e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	2.88e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.88e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.85e-05	0.000219	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.83e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	2.83e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.73e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.71e-05	0.000208	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.7e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.63e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.63e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.55e-05	0.000196	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.55e-05	0.000196	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.53e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.45e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	2.43e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.37e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.37e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.37e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.3e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.29e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	2.27e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.25e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.23e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.23e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.2e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.15e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	2.15e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	2.13e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.07e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.07e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.07e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.97e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.95e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.92e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.86e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	1.84e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.81e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.81e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	1.73e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.68e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.45e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.27e-05	9.75e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.18e-05	9.06e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	9.2e-06	7.07e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.24e-06	6.33e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.7e-06	5.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	7.47e-06	5.74e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.73e-06	5.16e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.25e-06	4.8e-05	CbGpPWpGaD
